Description
Xylem, Inc.: An Insight Into Its Market Dynamics & Growth Potential in MCS!
Xylem’s fourth-quarter and full-year 2024 results demonstrate a robust performance, setting new benchmarks in revenue, EBITDA margins, and EPS. Revenue increased by 6%, EBITDA margins expanded by 170 basis points, and EPS rose by double digits. The company’s operational discipline and successful integration of Evoqua, which is delivering cost synergies faster than expected, underpin these achievements. Xylem’s segments exhibited healthy performance, with all achieving at least mid-single-digit growth in fourth-quarter orders. The company’s backlog remains strong at $5.1 billion, reflecting resilient demand, particularly in Water Infrastructure and Measurement & Control Solutions (MCS).
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
